Thursday, November 6, 2014

Abbvie Inc. (ABBV) Trading At A Deep Discount, But With Risks

Linked here is a detailed quantitative analysis of Abbvie Inc. (ABBV). Below are some highlights from the above linked analysis:

Company Description: Abbvie Inc. is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis.

Continue Reading »

No comments:

Post a Comment

Popular Posts - Last 7 days